Dentsply Sirona (XRAY) Cash & Equivalents (2009 - 2026)

Dentsply Sirona (XRAY) has 18 years of Cash & Equivalents data on file, last reported at $190.0 million in Q1 2026.

• Quarterly Cash & Equivalents fell 52.26% year-over-year to $190.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $190.0 million (down 52.26% YoY) and the FY2025 annual result came in at $326.0 million, up 19.85% from the prior year.
• Cash & Equivalents eased to $190.0 million in Q1 2026, from $326.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $418.0 million in Q3 2022 to a low of $190.0 million in Q1 2026.
• A 5-year average of $326.4 million and a median of $326.0 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 48.75% — and 2026, when it plunged 52.26%.
• Tracing XRAY's Cash & Equivalents over 5 years: stood at $365.0 million in 2022, then decreased by 8.49% to $334.0 million in 2023, then decreased by 18.56% to $272.0 million in 2024, then rose by 19.85% to $326.0 million in 2025, then plunged by 41.72% to $190.0 million in 2026.
• The last three Cash & Equivalents figures came in at $190.0 million (Q1 2026), $326.0 million (Q4 2025), and $363.0 million (Q3 2025), per Business Quant data.